Abstract
Inhalant allergy to arthropods is of major social, economic, and medical importance. As seen in this review, immunologic techniques for evaluating the multitude of clinical problems that are known to exist are beginning to enable the clinical allergist to deal with these problems in more effective ways. Successful application of newer biotechnology methods in areas of protein isolation, characterization, and sequencing together with gene cloning technology should result in significant advances in our understanding and management of inhalant arthropod allergy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
